|Place of Origin:||China|
|Minimum Order Quantity:||Negotiable|
|Packaging Details:||Foil bag or Disguised package|
|Delivery Time:||3-5 work days|
|Payment Terms:||T/T, Western Union, MoneyGram, Bitcoins|
|Supply Ability:||Mass in Stock|
|Appearance:||White Power||Single Impurity(HPLC):||1.0%|
muscle growth peptides,
human growth hormone powder
|CJC-1295 CAS No.||863288-34-0|
|CJC-1295 Molecular Formula||C152H252N44O42|
|CJC-1295 Molecular weight||3367.2|
|CJC-1295 Synonyms||CJC 1295 w/o DAC, MOD GRF 1-29, Neorelin, Modified Sermorelin|
|CJC-1295 purity||98% min|
|CJC-1295 Appearance||White lyophilized powder|
|CJC-1295 Related substance||Total Impurities (%) ≤ 2.0%|
|CJC-1295 Bacterial Endotoxins||≤5 IU/mg|
|CJC-1295 Source||Chemical Synthesis|
|CJC-1295 Shelf life||One year from dispatch|
CJC-1295 without DAC is a protein that is 29 amino acids long and it is a GHRH analogue. CJC-1295 without DAC acts on receptors at the pituitary gland to stimulate the release of Human Growth Hormone. CJC-1295 could be referred to as a second generation derivative of GHRH, which is modified to create Releasing Factor 1-29, also known as Sermorelin. GRF 1-29 is then further modified to create Mod GRF 1-29 which is CJC-1295 without DAC.
Application & Effects
One of CJC-1295 benefits is linked to the peptide is the boosting of protein synthesis. Studies have led to the theory that the peptide's ability to prevent natural cellular degradation can increase the amount of proteins in animal test subjects. Another theorized benefit revolves around the notion of reduced body fat, as the peptide's mechanics have demonstrated a tendency to promote lipolysis, which is the process where lipids get broken down.
As a result of this accelerated degradation of lipids over time, the level of body fat within an animal test subject has shown signs of dropping.
CJC-1295 Injection may be subcutaneous, intramuscular, or intravenous.
According to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe. This reduces the total number of injections required.
We recommend a dosage of 100 mcg CJC-1295 at a time, simultaneous with injection of a GHRP.
For maximum effect, dosing is preferably three times per day at times of low blood sugar, for example about 30 minutes before a meal, but where use is ongoing, a common use is once per day prior to sleep.
Related Products as below:
|CJC-1295 with DAC||2mg/vial||500|
|CJC-1295 without DAC||2mg/vial||500|
|pentadecapeptide BPC 157||2mg/vial||500|
Contact Person: Moran